Report Cover

Global Biodefense Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Biodefense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biodefense size is estimated to be USD 1437.3 million in 2026 from USD 1097.1 million in 2020, with a change XX% between 2020 and 2021. The global Biodefense market size is expected to grow at a CAGR of 7.0% for the next five years.

Market segmentation
Biodefense market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Anthrax
    Smallpox
    Botulism
    Radiation/Nuclear
    Others

Market segment by Application, can be divided into
    US Military Market
    US Civilian Market
    Non - US Market

Market segment by players, this report covers
    Emergent Biosolutions
    Hytest
    GSK
    Sanofi
    PharmAthene
    Bavarian Nordic
    SIGA Technologies
    Arbutus Biopharma
    DynPort Vaccine
    Xoma Corporation
    Ichor Medical Systems
    Aeolus Pharmaceuticals
    Achaogen
    Elusys Therapeutics
    Dynavax Technologies
    Cleveland BioLabs
    Soligenix
    Alnylam Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biodefense product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biodefense, with revenue, gross margin and global market share of Biodefense from 2019 to 2021.
Chapter 3, the Biodefense competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Biodefense market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Biodefense research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Biodefense
    1.2 Classification of Biodefense by Type
        1.2.1 Overview: Global Biodefense Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Biodefense Revenue Market Share by Type in 2020
        1.2.3 Anthrax
        1.2.4 Smallpox
        1.2.5 Botulism
        1.2.6 Radiation/Nuclear
        1.2.7 Others
    1.3 Global Biodefense Market by Application
        1.3.1 Overview: Global Biodefense Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 US Military Market
        1.3.3 US Civilian Market
        1.3.4 Non - US Market
    1.4 Global Biodefense Market Size & Forecast
    1.5 Global Biodefense Market Size and Forecast by Region
        1.5.1 Global Biodefense Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Biodefense Market Size by Region, (2016-2021)
        1.5.3 North America Biodefense Market Size and Prospect (2016-2026)
        1.5.4 Europe Biodefense Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Biodefense Market Size and Prospect (2016-2026)
        1.5.6 South America Biodefense Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Biodefense Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biodefense Market Drivers
        1.6.2 Biodefense Market Restraints
        1.6.3 Biodefense Trends Analysis
2 Company Profiles
    2.1 Emergent Biosolutions
        2.1.1 Emergent Biosolutions Details
        2.1.2 Emergent Biosolutions Major Business
        2.1.3 Emergent Biosolutions Biodefense Product and Solutions
        2.1.4 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Emergent Biosolutions Recent Developments and Future Plans
    2.2 Hytest
        2.2.1 Hytest Details
        2.2.2 Hytest Major Business
        2.2.3 Hytest Biodefense Product and Solutions
        2.2.4 Hytest Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Hytest Recent Developments and Future Plans
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Biodefense Product and Solutions
        2.3.4 GSK Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 GSK Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Biodefense Product and Solutions
        2.4.4 Sanofi Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 PharmAthene
        2.5.1 PharmAthene Details
        2.5.2 PharmAthene Major Business
        2.5.3 PharmAthene Biodefense Product and Solutions
        2.5.4 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 PharmAthene Recent Developments and Future Plans
    2.6 Bavarian Nordic
        2.6.1 Bavarian Nordic Details
        2.6.2 Bavarian Nordic Major Business
        2.6.3 Bavarian Nordic Biodefense Product and Solutions
        2.6.4 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Bavarian Nordic Recent Developments and Future Plans
    2.7 SIGA Technologies
        2.7.1 SIGA Technologies Details
        2.7.2 SIGA Technologies Major Business
        2.7.3 SIGA Technologies Biodefense Product and Solutions
        2.7.4 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 SIGA Technologies Recent Developments and Future Plans
    2.8 Arbutus Biopharma
        2.8.1 Arbutus Biopharma Details
        2.8.2 Arbutus Biopharma Major Business
        2.8.3 Arbutus Biopharma Biodefense Product and Solutions
        2.8.4 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Arbutus Biopharma Recent Developments and Future Plans
    2.9 DynPort Vaccine
        2.9.1 DynPort Vaccine Details
        2.9.2 DynPort Vaccine Major Business
        2.9.3 DynPort Vaccine Biodefense Product and Solutions
        2.9.4 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 DynPort Vaccine Recent Developments and Future Plans
    2.10 Xoma Corporation 
        2.10.1 Xoma Corporation Details
        2.10.2 Xoma Corporation Major Business
        2.10.3 Xoma Corporation Biodefense Product and Solutions
        2.10.4 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Xoma Corporation Recent Developments and Future Plans
    2.11 Ichor Medical Systems
        2.11.1 Ichor Medical Systems Details
        2.11.2 Ichor Medical Systems Major Business
        2.11.3 Ichor Medical Systems Biodefense Product and Solutions
        2.11.4 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Ichor Medical Systems Recent Developments and Future Plans
    2.12 Aeolus Pharmaceuticals
        2.12.1 Aeolus Pharmaceuticals Details
        2.12.2 Aeolus Pharmaceuticals Major Business
        2.12.3 Aeolus Pharmaceuticals Biodefense Product and Solutions
        2.12.4 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Aeolus Pharmaceuticals Recent Developments and Future Plans
    2.13 Achaogen
        2.13.1 Achaogen Details
        2.13.2 Achaogen Major Business
        2.13.3 Achaogen Biodefense Product and Solutions
        2.13.4 Achaogen Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Achaogen Recent Developments and Future Plans
    2.14 Elusys Therapeutics
        2.14.1 Elusys Therapeutics Details
        2.14.2 Elusys Therapeutics Major Business
        2.14.3 Elusys Therapeutics Biodefense Product and Solutions
        2.14.4 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Elusys Therapeutics Recent Developments and Future Plans
    2.15 Dynavax Technologies
        2.15.1 Dynavax Technologies Details
        2.15.2 Dynavax Technologies Major Business
        2.15.3 Dynavax Technologies Biodefense Product and Solutions
        2.15.4 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Dynavax Technologies Recent Developments and Future Plans
    2.16 Cleveland BioLabs
        2.16.1 Cleveland BioLabs Details
        2.16.2 Cleveland BioLabs Major Business
        2.16.3 Cleveland BioLabs Biodefense Product and Solutions
        2.16.4 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Cleveland BioLabs Recent Developments and Future Plans
    2.17 Soligenix
        2.17.1 Soligenix Details
        2.17.2 Soligenix Major Business
        2.17.3 Soligenix Biodefense Product and Solutions
        2.17.4 Soligenix Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Soligenix Recent Developments and Future Plans
    2.18 Alnylam Pharmaceuticals
        2.18.1 Alnylam Pharmaceuticals Details
        2.18.2 Alnylam Pharmaceuticals Major Business
        2.18.3 Alnylam Pharmaceuticals Biodefense Product and Solutions
        2.18.4 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biodefense Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biodefense Players Market Share
        3.2.2 Top 10 Biodefense Players Market Share
        3.2.3 Market Competition Trend
    3.3 Biodefense Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biodefense Revenue and Market Share by Type (2016-2021)
    4.2 Global Biodefense Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Biodefense Revenue Market Share by Application (2016-2021)
    5.2 Biodefense Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Biodefense Revenue by Type (2016-2026)
    6.2 North America Biodefense Revenue by Application (2016-2026)
    6.3 North America Biodefense Market Size by Country
        6.3.1 North America Biodefense Revenue by Country (2016-2026)
        6.3.2 United States Biodefense Market Size and Forecast (2016-2026)
        6.3.3 Canada Biodefense Market Size and Forecast (2016-2026)
        6.3.4 Mexico Biodefense Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biodefense Revenue by Type (2016-2026)
    7.2 Europe Biodefense Revenue by Application (2016-2026)
    7.3 Europe Biodefense Market Size by Country
        7.3.1 Europe Biodefense Revenue by Country (2016-2026)
        7.3.2 Germany Biodefense Market Size and Forecast (2016-2026)
        7.3.3 France Biodefense Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Biodefense Market Size and Forecast (2016-2026)
        7.3.5 Russia Biodefense Market Size and Forecast (2016-2026)
        7.3.6 Italy Biodefense Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biodefense Revenue by Type (2016-2026)
    8.2 Asia-Pacific Biodefense Revenue by Application (2016-2026)
    8.3 Asia-Pacific Biodefense Market Size by Region
        8.3.1 Asia-Pacific Biodefense Revenue by Region (2016-2026)
        8.3.2 China Biodefense Market Size and Forecast (2016-2026)
        8.3.3 Japan Biodefense Market Size and Forecast (2016-2026)
        8.3.4 South Korea Biodefense Market Size and Forecast (2016-2026)
        8.3.5 India Biodefense Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Biodefense Market Size and Forecast (2016-2026)
        8.3.7 Australia Biodefense Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Biodefense Revenue by Type (2016-2026)
    9.2 South America Biodefense Revenue by Application (2016-2026)
    9.3 South America Biodefense Market Size by Country
        9.3.1 South America Biodefense Revenue by Country (2016-2026)
        9.3.2 Brazil Biodefense Market Size and Forecast (2016-2026)
        9.3.3 Argentina Biodefense Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biodefense Revenue by Type (2016-2026)
    10.2 Middle East & Africa Biodefense Revenue by Application (2016-2026)
    10.3 Middle East & Africa Biodefense Market Size by Country
        10.3.1 Middle East & Africa Biodefense Revenue by Country (2016-2026)
        10.3.2 Turkey Biodefense Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Biodefense Market Size and Forecast (2016-2026)
        10.3.4 UAE Biodefense Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Biodefense Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Biodefense Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Biodefense Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Biodefense Revenue (USD Million) by Region (2016-2021) Table 5. Global Biodefense Revenue Market Share by Region (2021-2026) Table 6. Emergent Biosolutions Corporate Information, Head Office, and Major Competitors Table 7. Emergent Biosolutions Major Business Table 8. Emergent Biosolutions Biodefense Product and Solutions Table 9. Emergent Biosolutions Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Hytest Corporate Information, Head Office, and Major Competitors Table 11. Hytest Major Business Table 12. Hytest Biodefense Product and Solutions Table 13. Hytest Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. GSK Corporate Information, Head Office, and Major Competitors Table 15. GSK Major Business Table 16. GSK Biodefense Product and Solutions Table 17. GSK Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Sanofi Corporate Information, Head Office, and Major Competitors Table 19. Sanofi Major Business Table 20. Sanofi Biodefense Product and Solutions Table 21. Sanofi Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. PharmAthene Corporate Information, Head Office, and Major Competitors Table 23. PharmAthene Major Business Table 24. PharmAthene Biodefense Product and Solutions Table 25. PharmAthene Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Bavarian Nordic Corporate Information, Head Office, and Major Competitors Table 27. Bavarian Nordic Major Business Table 28. Bavarian Nordic Biodefense Product and Solutions Table 29. Bavarian Nordic Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. SIGA Technologies Corporate Information, Head Office, and Major Competitors Table 31. SIGA Technologies Major Business Table 32. SIGA Technologies Biodefense Product and Solutions Table 33. SIGA Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Arbutus Biopharma Corporate Information, Head Office, and Major Competitors Table 35. Arbutus Biopharma Major Business Table 36. Arbutus Biopharma Biodefense Product and Solutions Table 37. Arbutus Biopharma Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. DynPort Vaccine Corporate Information, Head Office, and Major Competitors Table 39. DynPort Vaccine Major Business Table 40. DynPort Vaccine Biodefense Product and Solutions Table 41. DynPort Vaccine Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Xoma Corporation Corporate Information, Head Office, and Major Competitors Table 43. Xoma Corporation Major Business Table 44. Xoma Corporation Biodefense Product and Solutions Table 45. Xoma Corporation Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Ichor Medical Systems Corporate Information, Head Office, and Major Competitors Table 47. Ichor Medical Systems Major Business Table 48. Ichor Medical Systems Biodefense Product and Solutions Table 49. Ichor Medical Systems Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Aeolus Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 51. Aeolus Pharmaceuticals Major Business Table 52. Aeolus Pharmaceuticals Biodefense Product and Solutions Table 53. Aeolus Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Achaogen Corporate Information, Head Office, and Major Competitors Table 55. Achaogen Major Business Table 56. Achaogen Biodefense Product and Solutions Table 57. Achaogen Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Elusys Therapeutics Corporate Information, Head Office, and Major Competitors Table 59. Elusys Therapeutics Major Business Table 60. Elusys Therapeutics Biodefense Product and Solutions Table 61. Elusys Therapeutics Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Dynavax Technologies Corporate Information, Head Office, and Major Competitors Table 63. Dynavax Technologies Major Business Table 64. Dynavax Technologies Biodefense Product and Solutions Table 65. Dynavax Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Cleveland BioLabs Corporate Information, Head Office, and Major Competitors Table 67. Cleveland BioLabs Major Business Table 68. Cleveland BioLabs Biodefense Product and Solutions Table 69. Cleveland BioLabs Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Soligenix Corporate Information, Head Office, and Major Competitors Table 71. Soligenix Major Business Table 72. Soligenix Biodefense Product and Solutions Table 73. Soligenix Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 75. Alnylam Pharmaceuticals Major Business Table 76. Alnylam Pharmaceuticals Biodefense Product and Solutions Table 77. Alnylam Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. Global Biodefense Revenue (USD Million) by Players (2019-2021) Table 79. Global Biodefense Revenue Share by Players (2019-2021) Table 80. Breakdown of Biodefense by Company Type (Tier 1, Tier 2 and Tier 3) Table 81. Biodefense Players Head Office, Products and Services Provided Table 82. Biodefense Mergers & Acquisitions in the Past Five Years Table 83. Biodefense New Entrants and Expansion Plans Table 84. Global Biodefense Revenue (USD Million) by Type (2016-2021) Table 85. Global Biodefense Revenue Share by Type (2016-2021) Table 86. Global Biodefense Revenue Forecast by Type (2021-2026) Table 87. Global Biodefense Revenue by Application (2016-2021) Table 88. Global Biodefense Revenue Forecast by Application (2021-2026) Table 89. North America Biodefense Revenue by Type (2016-2021) & (USD Million) Table 90. North America Biodefense Revenue by Type (2021-2026) & (USD Million) Table 91. North America Biodefense Revenue by Application (2016-2021) & (USD Million) Table 92. North America Biodefense Revenue by Application (2021-2026) & (USD Million) Table 93. North America Biodefense Revenue by Country (2016-2021) & (USD Million) Table 94. North America Biodefense Revenue by Country (2021-2026) & (USD Million) Table 95. Europe Biodefense Revenue by Type (2016-2021) & (USD Million) Table 96. Europe Biodefense Revenue by Type (2021-2026) & (USD Million) Table 97. Europe Biodefense Revenue by Application (2016-2021) & (USD Million) Table 98. Europe Biodefense Revenue by Application (2021-2026) & (USD Million) Table 99. Europe Biodefense Revenue by Country (2016-2021) & (USD Million) Table 100. Europe Biodefense Revenue by Country (2021-2026) & (USD Million) Table 101. Asia-Pacific Biodefense Revenue by Type (2016-2021) & (USD Million) Table 102. Asia-Pacific Biodefense Revenue by Type (2021-2026) & (USD Million) Table 103. Asia-Pacific Biodefense Revenue by Application (2016-2021) & (USD Million) Table 104. Asia-Pacific Biodefense Revenue by Application (2021-2026) & (USD Million) Table 105. Asia-Pacific Biodefense Revenue by Region (2016-2021) & (USD Million) Table 106. Asia-Pacific Biodefense Revenue by Region (2021-2026) & (USD Million) Table 107. South America Biodefense Revenue by Type (2016-2021) & (USD Million) Table 108. South America Biodefense Revenue by Type (2021-2026) & (USD Million) Table 109. South America Biodefense Revenue by Application (2016-2021) & (USD Million) Table 110. South America Biodefense Revenue by Application (2021-2026) & (USD Million) Table 111. South America Biodefense Revenue by Country (2016-2021) & (USD Million) Table 112. South America Biodefense Revenue by Country (2021-2026) & (USD Million) Table 113. Middle East & Africa Biodefense Revenue by Type (2016-2021) & (USD Million) Table 114. Middle East & Africa Biodefense Revenue by Type (2021-2026) & (USD Million) Table 115. Middle East & Africa Biodefense Revenue by Application (2016-2021) & (USD Million) Table 116. Middle East & Africa Biodefense Revenue by Application (2021-2026) & (USD Million) Table 117. Middle East & Africa Biodefense Revenue by Country (2016-2021) & (USD Million) Table 118. Middle East & Africa Biodefense Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Biodefense Picture Figure 2. Global Biodefense Revenue Market Share by Type in 2020 Figure 3. Anthrax Figure 4. Smallpox Figure 5. Botulism Figure 6. Radiation/Nuclear Figure 7. Others Figure 8. Biodefense Revenue Market Share by Application in 2020 Figure 9. US Military Market Picture Figure 10. US Civilian Market Picture Figure 11. Non - US Market Picture Figure 12. Global Biodefense Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 13. Global Biodefense Revenue and Forecast (2016-2026) & (USD Million) Figure 14. Global Biodefense Revenue Market Share by Region (2016-2026) Figure 15. Global Biodefense Revenue Market Share by Region in 2020 Figure 16. North America Biodefense Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Europe Biodefense Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. Asia-Pacific Biodefense Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. South America Biodefense Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. Middle East and Africa Biodefense Revenue (USD Million) and Growth Rate (2016-2026) Figure 21. Biodefense Market Drivers Figure 22. Biodefense Market Restraints Figure 23. Biodefense Market Trends Figure 24. Emergent Biosolutions Recent Developments and Future Plans Figure 25. Hytest Recent Developments and Future Plans Figure 26. GSK Recent Developments and Future Plans Figure 27. Sanofi Recent Developments and Future Plans Figure 28. PharmAthene Recent Developments and Future Plans Figure 29. Bavarian Nordic Recent Developments and Future Plans Figure 30. SIGA Technologies Recent Developments and Future Plans Figure 31. Arbutus Biopharma Recent Developments and Future Plans Figure 32. DynPort Vaccine Recent Developments and Future Plans Figure 33. Xoma Corporation Recent Developments and Future Plans Figure 34. Ichor Medical Systems Recent Developments and Future Plans Figure 35. Aeolus Pharmaceuticals Recent Developments and Future Plans Figure 36. Achaogen Recent Developments and Future Plans Figure 37. Elusys Therapeutics Recent Developments and Future Plans Figure 38. Dynavax Technologies Recent Developments and Future Plans Figure 39. Cleveland BioLabs Recent Developments and Future Plans Figure 40. Soligenix Recent Developments and Future Plans Figure 41. Alnylam Pharmaceuticals Recent Developments and Future Plans Figure 42. Global Biodefense Revenue Share by Players in 2020 Figure 43. Biodefense Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 44. Global Top 3 Players Biodefense Revenue Market Share in 2020 Figure 45. Global Top 10 Players Biodefense Revenue Market Share in 2020 Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 47. Global Biodefense Revenue Share by Type in 2020 Figure 48. Global Biodefense Market Share Forecast by Type (2021-2026) Figure 49. Global Biodefense Revenue Share by Application in 2020 Figure 50. Global Biodefense Market Share Forecast by Application (2021-2026) Figure 51. North America Biodefense Sales Market Share by Type (2016-2026) Figure 52. North America Biodefense Sales Market Share by Application (2016-2026) Figure 53. North America Biodefense Revenue Market Share by Country (2016-2026) Figure 54. United States Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 55. Canada Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. Mexico Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. Europe Biodefense Sales Market Share by Type (2016-2026) Figure 58. Europe Biodefense Sales Market Share by Application (2016-2026) Figure 59. Europe Biodefense Revenue Market Share by Country (2016-2026) Figure 60. Germany Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. France Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. United Kingdom Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. Russia Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Italy Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Asia-Pacific Biodefense Sales Market Share by Type (2016-2026) Figure 66. Asia-Pacific Biodefense Sales Market Share by Application (2016-2026) Figure 67. Asia-Pacific Biodefense Revenue Market Share by Region (2016-2026) Figure 68. China Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. Japan Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. South Korea Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. India Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Southeast Asia Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Australia Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. South America Biodefense Sales Market Share by Type (2016-2026) Figure 75. South America Biodefense Sales Market Share by Application (2016-2026) Figure 76. South America Biodefense Revenue Market Share by Country (2016-2026) Figure 77. Brazil Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Argentina Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. Middle East and Africa Biodefense Sales Market Share by Type (2016-2026) Figure 80. Middle East and Africa Biodefense Sales Market Share by Application (2016-2026) Figure 81. Middle East and Africa Biodefense Revenue Market Share by Country (2016-2026) Figure 82. Turkey Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 83. Saudi Arabia Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 84. UAE Biodefense Revenue and Growth Rate (2016-2026) & (USD Million) Figure 85. Methodology Figure 86. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us